ChemoCentryx Inc (NASDAQ:CCXI) Pulls Out From ANCA-Associated Vasculitis Phase II-Based Conditional Marketing Authorization Application – FDA Headlines

ChemoCentryx Inc (NASDAQ:CCXI) Pulls Out From ANCA-Associated Vasculitis Phase II-Based Conditional Marketing Authorization Application – FDA Headlines

ChemoCentryx Inc (NASDAQ:CCXI) Pulls Out From ANCA-Associated Vasculitis Phase II-Based Conditional Marketing Authorization Application – FDA Headlines
Published on 2019-02-14